Skip to main content

Advertisement

Log in

Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature

  • Case Based Review - Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Antisynthetase syndrome is a heterogeneous idiopathic inflammatory myopathy. Anti-Jo1 is the most common antibody found in this condition. Dermatomyositis is known to be associated with malignancy, but the association between antisynthetase syndrome and malignancy is not clearly established. We report a case of an association of squamous cell carcinoma of the lung and anti-Jo1 antisynthetase syndrome. A 67-year-old man presented with polyarthritis, muscle weakness of the pelvic girdle, “mechanic’s hands,” and weight loss. A diagnosis of antisynthetase syndrome was considered based on the clinical features and the presence of anti-Jo1 antibodies. Positron emission tomography was performed because of weight loss and revealed a pulmonary hypermetabolic lesion. Histological findings revealed squamous cell carcinoma. The patient underwent lobectomy and is currently free of symptoms with regular monitoring. This unusual presentation of squamous cell carcinoma of the lung illustrates the need of a systematic approach to the diagnosis of antisynthetase syndrome. Positron emission tomography can be a useful imaging modality in the diagnosis of paraneoplastic syndromes associated with antisynthetase syndrome especially in the presence of warning signs/symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M et al (2010) Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology 49:972–976

    Article  CAS  PubMed  Google Scholar 

  2. Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A et al (2013) Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res 65:800–808

    Article  CAS  Google Scholar 

  3. Buchbinder R, Hill CL (2002) Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 4:415–426

    Article  PubMed  Google Scholar 

  4. Marie I, Guillevin L, Menard J-F, Hatron PY, Cherin P, Amoura Z et al (2012) Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev 11:615–620

    Article  CAS  PubMed  Google Scholar 

  5. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. The Lancet 357:96–100

    Article  CAS  Google Scholar 

  6. Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Chérin P (2003) Antisynthetase syndrome. Jt Bone Spine 70:161–168

    Article  Google Scholar 

  7. Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A et al (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 12:210–217

    Article  CAS  PubMed  Google Scholar 

  8. Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard J-F et al (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41:890–899

    Article  CAS  PubMed  Google Scholar 

  9. Iwasaki Y, Mohri T, Muraki M, Yasukawa A, Fujimoto T, Takagi O (1992) et al [A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma]. Nihon Kyōbu Shikkan Gakkai Zasshi 30:1858–1863

    CAS  PubMed  Google Scholar 

  10. Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Beynon HLC (2004) Jo-1 syndrome with associated poorly differentiated adenocarcinoma. Rheumatol Oxf 43:389–390

    Article  CAS  Google Scholar 

  11. van der Bijl AE, Meinders AE, van Duinen SG, Tamsma JT (2005) A nasal squamous cell carcinoma complicated by a paraneoplastic syndrome consisting of a myositis and anti-Jo-1 autoantibodies. Eur J Intern Med 16:369–371

    Article  PubMed  Google Scholar 

  12. Nakanishi S (2006) Hatayama T [Adenocarcinoma of the prostate associated with anti Jo-1 antibody positive polymyositis]. Hinyokika Kiyo 52:289–291

    PubMed  Google Scholar 

  13. Respicio G, Shwaiki W, Abeles M (2007) A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussion. Conn Med 71:151–153

    PubMed  Google Scholar 

  14. Legault D, McDermott J, Crous-Tsanaclis AM, Boire G (2008) Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome. J Rheumatol 35:169–171

    PubMed  Google Scholar 

  15. Rozelle A, Trieu S, Chung L (2008) Malignancy in the setting of the anti-synthetase syndrome. J Clin Rheumatol 14:285–288

    Article  PubMed  Google Scholar 

  16. Przybylski G, Jarzemska A, Czerniak J, Siemiatkowska K, Gadzińska A, Cieśliński K (2008) A case report of a patient with dermatomyositis as a prodromal sign of lung cancer. Pol Arch Med Wewnętrznej 118:143–147

    Google Scholar 

  17. Mileti LM, Strek ME, Niewold TB, Curran JJ, Sweiss NJ (2009) Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol 15:254–255

    Article  PubMed  PubMed Central  Google Scholar 

  18. Castañeda-Pomeda M, Prieto-González S, Grau JM (2011) Antisynthetase syndrome and malignancy: our experience. J Clin Rheumatol 17:458

    Article  PubMed  Google Scholar 

  19. Vincze M, Molnár PA, Zilahi E, Kapitány A, Dezso B, Takács I et al (2011) Primary lung adenocarcinoma associated with anti-Jo-1 positive polymyositis. Jt Bone Spine 78:209–211

    Article  Google Scholar 

  20. Bragado L, Ruiz Gutiérrez L, Cuende E, López González JL (2013) Kaposi’s sarcoma in a steroid-treated antisynthethase antibody syndrome patient. Reumatol Clin 9:243–245

    Article  PubMed  Google Scholar 

  21. Courties A, Lidove O, Maisonobe T, Rigolet A, Hermet A, Girard P (2014) et al [Antisynthetase syndrome and lung carcinoma: a fortuitous association?]. Rev Méd Intern 35:271–273

    Article  CAS  Google Scholar 

  22. Marie I, Hatron P-Y, Cherin P, Hachulla E, Diot E, Vittecoq O et al (2013) Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome. Arthritis Res Ther 15:R149

    Article  PubMed  PubMed Central  Google Scholar 

  23. Trallero-Araguás E, Grau-Junyent JM, Labirua-Iturburu A, García-Hernández FJ, Monteagudo-Jiménez M, Fraile-Rodriguez G et al (2016) Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Semin Arthritis Rheum 46(2):225–231

    Article  PubMed  Google Scholar 

  24. Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11:739–745

    Article  CAS  PubMed  Google Scholar 

  25. Corte RL, naco ALM, Locaputo A, Dolzani F, Trotta F (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39:249–253

    Article  PubMed  Google Scholar 

  26. Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E et al (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71:961–965

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors did not receive any grant or industrial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Boleto.

Ethics declarations

Conflits of interest

The authors state explicitly that there are no conflicts of interest in connection with this article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boleto, G., Perotin, JM., Eschard, JP. et al. Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature. Rheumatol Int 37, 1203–1206 (2017). https://doi.org/10.1007/s00296-017-3728-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3728-z

Keywords

Navigation